Agenus AGEN
NASDAQ AGEN
$8.32 +0.08 (+1.00%)
As of: Sep 4, 2026 · 1:39 PM EDT

Agenus (AGEN) Change in Acquisitions & Divestments (2010 - 2026)

Agenus (AGEN) posted quarterly Change in Acquisitions & Divestments of $7000.0 for Q1 2026, down 88.71% year-over-year from $62000.0 in Q1 2025, and up 111.29% quarter-over-quarter from -$62000.0 in Q4 2025.

Analysis

Agenus (AGEN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Agenus' Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $7000.0 for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 88.71% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at -$55000.0 (down 114.59% YoY), while the FY2024 annual figure was $579000.0, up 1602.94% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $7000.0, up from -$62000.0 in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $15.0 million in Q3 2023, with the low at -$30.0 million in Q4 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $264000.0 (2024), against an average of $1.7 million.
  • Peak annual rise in Change in Acquisitions & Divestments reached 200.0% in 2023, while the deepest fall reached 699.32% in 2023.
  • Agenus' Change in Acquisitions & Divestments stood at $5.0 million in 2022, then sank by 699.32% to -$30.0 million in 2023, then surged by 100.17% to $52000.0 in 2024, then plunged by 219.23% to -$62000.0 in 2025, then surged by 111.29% to $7000.0 in 2026.
  • Business Quant data shows AGEN's Change in Acquisitions & Divestments at $7000.0 in Q1 2026, -$62000.0 in Q4 2025, and $62000.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Agenus 344.35 Mn 344.35 Mn 34.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 779,000.00
Mar 31, 2025 62,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 39,000.00
Jun 30, 2024 224,000.00
Mar 31, 2024 264,000.00
Sep 30, 2023 15.00 Mn
Jun 30, 2023 10.00 Mn
Mar 31, 2023 5.00 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 10.00 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2017 5.00 Mn
Sep 30, 2017 10.00 Mn
Mar 31, 2017 5.00 Mn
Dec 31, 2016 15.00 Mn
Sep 30, 2016 35.00 Mn